BlackRock Fund Advisors’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$13.4M Buy
1,019,962
+141,735
+16% +$1.86M ﹤0.01% 2411
2016
Q3
$15.1M Buy
878,227
+50,875
+6% +$877K ﹤0.01% 2222
2016
Q2
$14.9M Buy
827,352
+70,177
+9% +$1.27M ﹤0.01% 2188
2016
Q1
$14.4M Sell
757,175
-36,101
-5% -$686K ﹤0.01% 2168
2015
Q4
$21.2M Buy
793,276
+36,939
+5% +$986K ﹤0.01% 2007
2015
Q3
$18.5M Buy
756,337
+113,106
+18% +$2.76M ﹤0.01% 2041
2015
Q2
$20M Sell
643,231
-4,720
-0.7% -$147K ﹤0.01% 2118
2015
Q1
$9.43M Buy
647,951
+7,134
+1% +$104K ﹤0.01% 2476
2014
Q4
$6.45M Buy
640,817
+99,151
+18% +$998K ﹤0.01% 2719
2014
Q3
$4.51M Buy
541,666
+63,395
+13% +$528K ﹤0.01% 2812
2014
Q2
$5.89M Buy
+478,271
New +$5.89M ﹤0.01% 2744